International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 15-19 , April 2010

Clinical significance of urinary Monocyte Chemoattractant Protein-1 (uMCP-1) in Indian type 2 diabetic patients at different stages of diabetic nephropathy

Received 20 July 2009 ,Revised 25 September 2009 ,Accepted 13 October 2009.

References 

  1. Ritz E. Advances in nephrology: successes and lessons from diabetes mellitus. Nephrol Dial Transpl. 2001;16(Suppl. 7):46–50
  2. Parving HH, Osterby R, Ritz E. Diabetic nephropathy. In:  Brenner BM editors. The kidney. 6th ed.. Philadelphia: W.B. Saunders Company; 2000;p. 1731–1773
  3. Cooper ME. Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet. 1998;352:213–219
  4. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis. 1993;21:480–485
  5. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, et al. Upregulation of MCP-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 2000;58:1492–1498
  6. Park IS, Kiyomoto H, Abboud SL, Abboud HE. Expression of transforming growth factor-β and type IV collagen in early streptozotocin induced diabetes. Diabetes. 1997;46:473–480
  7. Rovin BH, Phan LT. Chemotactic factors and renal inflammation. Am J Kidney Dis. 1998;31:1065–1084
  8. Rovin BH, Yoshiumura T, Tan L. Cytokine induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol. 1992;148:2148–2153
  9. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest. 1994;71:536–542
  10. Oppenheim JJ, Zachariae CoC, Mukaida N, Matsushima K. Properties of the novel proinflammatory super gene “intercrine” cytokine family. Annu Rev Immunol. 1991;12:503–633
  11. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int. 2000;58:684–690
  12. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis. 1996;27:640–646
  13. Wang Qui-yue, Chen Fen-qin. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Diab Res Clin Prac. 2009;83:215–219
  14. Berthold A, Ralph T, Bernhard A. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care. 2003;26:2421–2425
  15. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–34
  16. World Health Organization . Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999;
  17. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int. 1993;44:1036–1047
  18. Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 2006;17:368–377
  19. Morri T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diab Compl. 2003;17:11–15
  20. Tashiro K, Koyanagi I, Saitoh A, Shimizu A, Shike T, Ishiguro C, et al. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal. 2002;16:1–4
  21. Ibrahim S, Rashed L. Correlation of urinary monocyte chemoattractant protein-1 with other parameters of renal injury in type 2 diabetes mellitus. Saudi J Kid Dis Transpl. 2008;19:911–917
  22. Francesco C, Angelika M, Matteo M, Annalisa I, Maria F, Stefano T, et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care. 2002;25:1829–1834
  23. Bakker AJ. Detection of microalbuminuria. Diabetes Care. 1999;22:307–313

PII: S1877-5934(09)00055-1

doi: 10.1016/j.ijdm.2009.10.003

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 15-19 , April 2010

Article Tools